Reverse payment patent settlements in the pharmaceutical sector and competition law – do Lundbeck and Actavis help to bridge the views across the Atlantic regarding the delayed market entry of cheaper, generic medicines?
vastutusandmed
P. Dutt, T. Kerikmäe
ajakirja aastakäik number kuu
Vol. 13, 1
ilmumisaasta
leheküljed
p. 21-36
ISSN
1213-8770
TTÜ struktuuriüksus
keel
inglise
Dutt, P.K., Kerikmäe, T. Reverse payment patent settlements in the pharmaceutical sector and competition law – do Lundbeck and Actavis help to bridge the views across the Atlantic regarding the delayed market entry of cheaper, generic medicines? // International and comparative law review (2013) Vol. 13, 1, p. 21-36.